학술논문
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
Document Type
Article
Author
Banerjee, S.; Farina, N.; Tabet, N.; Henderson, C.; Knapp, M.; High, J.; Stirling, S.; Shepstone, L.; Fox, C.; Swart, A.M.; Fountain, J.; Ballard, C.; Francis, P.; Bentham, P.; Burns, A.; Howard, R.; Livingston, G.; Leroi, I.; Nilforooshan, R.; Nurock, S.; O’brien, J.; Price, A.; Thomas, A.J.; Telling, T.
Source
In: Health Technology Assessment . (Health Technology Assessment, 2023, 27(23))
Subject
Language
English
ISSN
20464924
13665278
13665278